Drug intelligence / Profile preview

Ciclosporin + Hydrocortisone

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

The combination of ciclosporin (also spelled cyclosporine) and hydrocortisone is used primarily for treating dry eye disease, particularly in patients with Sjögren's syndrome. This combination leverages the anti-inflammatory properties of both medications to provide both immediate relief (from hydrocortisone) and long-term management (from ciclosporin). Cyclosporine is an immunosuppressive agent that inhibits T cell activation by binding to cyclophilin-1, forming a complex that inhibits calcineurin. This prevents the activation of nuclear factor of activated T cells (NF-AT), reducing the production of inflammatory cytokines like IL-2, IL-4, interferon-gamma, and TNF-alpha[4]. Hydrocortisone is a corticosteroid with powerful anti-inflammatory properties that tends to cause fewer side effects than other steroids[5]. When used together, these medications have shown efficacy in treating severe dry eye symptoms in patients with Sjögren's syndrome. The combination provides faster symptom relief than ciclosporin alone, as hydrocortisone offers immediate anti-inflammatory effects while waiting for ciclosporin's effects to develop (which typically takes 1-2 weeks)[5]. ## Drug Interactions When cyclosporine and hydrocortisone are used together, they may alter the blood levels and effects of both medications[6]. The metabolism of cyclosporine can be decreased when combined with hydrocortisone phosphate[4]. Coadministration may result in elevated plasma concentrations of one or both drugs[3]. ## Clinical Evidence A study published in the Journal of Ophthalmology found that combining hydrocortisone and ciclosporin A could help ease eye symptoms in people with Sjögren's syndrome. The combination group tended to perform better in terms of visual acuity after six months compared to ciclosporin A alone[5]. The researchers concluded that short-term hydrocortisone combined with long-term ciclosporin A therapy could provide fast improvement of clinical symptoms and may have positive long-term effects on optical image quality[5]. ## Administration and Usage Typically, hydrocortisone is used short-term at the beginning of treatment to provide immediate symptom relief, while ciclosporin A is used for long-term management. This approach helps avoid the potential side effects associated with prolonged steroid use while maintaining therapeutic efficacy[5].

Other names
Cyclosporine + Hydrocortisone
02

Targets

GR (Glucocorticoid receptor)CN (Calcineurin)

Beyond the preview

Go deeper on Ciclosporin + Hydrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciclosporin + Hydrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call